BUST FENTANYL Act

This bill seeks to enhance the United States' efforts to combat the trafficking of illicit drugs, specifically focusing on fentanyl and methamphetamine. It modifies the annual International Narcotics Control Strategy Report to update information on chemical precursors for methamphetamine that significantly affect the U.S. Additionally, it requires a comprehensive study and report to Congress on efforts to address fentanyl and synthetic opioid trafficking originating from the People's Republic of China, India, Mexico, and other relevant countries. The report, to be submitted jointly by the Secretary of State and the Attorney General, will detail U.S. government efforts to secure commitments from the PRC regarding fentanyl precursors, assess PRC cooperation on financial systems and money laundering, and evaluate the effectiveness of international collaborations like the Trilateral Fentanyl Committee. It also mandates a classified briefing on efforts to establish Drug Enforcement Administration offices in the PRC and forge new partnerships with provincial authorities to counter illicit trafficking. A key provision prioritizes the identification and reporting of persons from the People's Republic of China involved in shipping fentanyl, its analogues, and precursors to Mexico or other countries producing fentanyl for the U.S., with this prioritization continuing until the PRC is no longer the primary source. Furthermore, the legislation expands the President's authority under the Fentanyl Sanctions Act to impose sanctions on foreign persons who knowingly engage in significant activities or financial transactions that materially contribute to opioid trafficking. This includes those who receive proceeds from such activities or provide substantial support. The bill also empowers the President to sanction political subdivisions, agencies, or instrumentalities of foreign governments, including state-owned financial institutions, and their senior officials, if they are found to be knowingly involved in or facilitating significant opioid trafficking activities. Finally, it amends existing law to require annual reports to identify significant source countries for methamphetamine affecting the U.S. and describe their governments' actions to combat precursor diversion and methamphetamine trafficking.